Company / Free Cash Flow per Share
Unicycive Therapeutics, Inc. Free Cash Flow per Share History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.53
FY2024
5-year range
-$1.03 / -$0.39
FY2022-FY2024
Trend
+48.8%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-0.39 to $-0.53 over the past 2 years.
Based on SEC 10-K filings.
-0.53 in FY2024.
Declined from $-0.39 to $-0.53 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, free cash flow per share increased 48.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.53 | +48.8% |
| FY2023 | -$1.03 | -165.9% |
| FY2022 | -$0.39 | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026